Please provide your email address to receive an email when new articles are posted on . Viloxazine is a noradrenergic/norepinephrine reuptake inhibitor, and trazodone ...

Preclinical research showed that DMT antidepressant effects were rapid and robust in a stress-based depression model. Find ...

The MarketWatch News Department was not involved in the creation of this content.-- Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents ...

SSRIs enhance CD8 T cell antitumor activity by inhibiting SERT, an immune checkpoint in tumors, suggesting potential repurposing for cancer immunotherapy. High intratumoral SERT levels correlate with ...

The FDA has started a priority review of Otsuka Pharma's triple-acting drug for attention-deficit hyperactivity disorder ...

This is the first installment in a series of articles about the science of various aspects of college life. Use of selective serotonin reuptake inhibitors, or SSRIs, has increased among college ...

Taking certain antidepressants at the time of a traumatic brain injury (TBI) is not associated with an increased risk of ...

EEG-based machine learning predicted SSRI treatment response in depression with high accuracy. Learn how brain signals could ...

As the clocks fall back for the end of daylight saving time and the season moves closer to winter, many people are often struck with seasonal affective disorder (SAD), better known as seasonal ...

FDA fast tracks ADHD drug centanafadine, targeting approval by July 24 for treatment across all age groups, based on phase 3 trial results.